tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SPHDF Stock Latest News

Santhera Pharmaceuticals Advances Vamorolone Study for Duchenne Muscular Dystrophy
Company AnnouncementsSanthera Pharmaceuticals Advances Vamorolone Study for Duchenne Muscular Dystrophy
5d ago
SPHDF
Santhera’s Earnings Call: Positive Outlook Amid Challenges
PremiumCompany Announcements
Santhera’s Earnings Call: Positive Outlook Amid Challenges
22d ago
Santhera Pharmaceuticals Reports Strong H1 2025 Growth
PremiumCompany Announcements
Santhera Pharmaceuticals Reports Strong H1 2025 Growth
1M ago
Santhera price target raised to CHF 30 from CHF 25 at H.C. Wainwright
PremiumThe Fly
Santhera price target raised to CHF 30 from CHF 25 at H.C. Wainwright
5M ago
Santhera Pharmaceuticals: Buy Rating Affirmed on Strong Commercial Traction and Promising Financial Outlook
PremiumRatings
Santhera Pharmaceuticals: Buy Rating Affirmed on Strong Commercial Traction and Promising Financial Outlook
5M ago
Santhera Pharmaceuticals: Transformative Year with AGAMREE Success
PremiumCompany AnnouncementsSanthera Pharmaceuticals: Transformative Year with AGAMREE Success
6M ago
Santhera Pharmaceuticals: Buy Rating Affirmed on Strategic Milestones and Growth Prospects
Premium
Ratings
Santhera Pharmaceuticals: Buy Rating Affirmed on Strategic Milestones and Growth Prospects
9M ago
Santhera price target lowered to CHF 25 from CHF 30 at H.C. Wainwright
Premium
The Fly
Santhera price target lowered to CHF 25 from CHF 30 at H.C. Wainwright
1y ago
Santhera price target raised to CHF 28 from CHF 24 at H.C. Wainwright
PremiumThe FlySanthera price target raised to CHF 28 from CHF 24 at H.C. Wainwright
2y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >